Recommendation
- https://www.nature.com/articles/s41575-022-00608-8Breakthroughs in hepatitis C research: from discovery to cure ...May 20, 2022 ... HCV became the first curable, chronic viral infection. The introduction of direct antiviral agents revolutionized antiviral treatment, leading to viral ...
- PubMedhttps://pubmed.ncbi.nlm.nih.gov/35595834/Breakthroughs in hepatitis C research: from discovery to cureMay 20, 2022 ... In the 1970s, an unknown virus was suspected for documented cases of transfusion-associated hepatitis, a phenomenon called non-A, ...
- CDChttps://www.cdc.gov/media/releases/2023/p0629-hepatitis-c.htmlBreakthrough Cures for Hepatitis C Still Fail to Reach the Vast ...Jun 29, 2023 ... Breakthrough Cures for Hepatitis C Still Fail to Reach the Vast Majority of Americans Who Need Them ... A new CDC report suggests the majority of ...
- https://slidesgo.com/theme/universal-hepatitis-c-treatment-breakthroughUniversal Hepatitis C Treatment Breakthrough | Google SlidesMake a breakthrough presentation about universal hepatitis C treatment with this Google Slides and PowerPoint template.
- STAThttps://www.statnews.com/2016/09/13/lab-breakthrough-hepatitis-c/The lab breakthrough that paved the way for hepatitis C curesSep 13, 2016 ... They'll share the foundation's award for clinical medical research with Michael Sofia, an industry scientist who invented the hepatitis C drug ...
- Drug Topicshttps://www.drugtopics.com/view/breakthrough-vaccine-for-chronic-hepatitis-b-enters-first-in-human-trialBreakthrough Vaccine for Chronic Hepatitis B Enters First In-Human ...Feb 23, 2024 ... With over 3% of the world's population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a ...
- Medscapehttps://www.medscape.com/viewarticle/999756The Breakthrough Drug Whose Full Promise Remains UnrealizedJan 22, 2024 ... On December 6, 2013, the US Food and Drug Administration (FDA) approved sofosbuvir for the treatment of HCV, ushering in a new era of therapy.
- https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-fda-fast-track-designation-for-bepirovirsen-in-chronic-hepatitis-b/GSK receives US FDA Fast Track designation for bepirovirsen in ...Feb 12, 2024 ... B-Clear identified that patients with low baseline hepatitis B surface antigen levels are most likely to benefit from treatment with ...
- https://www.uptodate.com/contents/management-of-chronic-hepatitis-c-virus-infection-initial-antiviral-therapy-in-adultsManagement of chronic hepatitis C virus infection: Initial antiviral ...Jan 24, 2024 ... Management of chronic hepatitis C virus infection: Initial antiviral therapy in adults. Formulary drug information for this topic.
- News-Medicalhttps://www.news-medical.net/news/20240821/Breakthrough-treatment-reduces-liver-fibrosis-in-Hepatitis-C-patients.aspxBreakthrough treatment reduces liver fibrosis in Hepatitis C patientsAug 21, 2024 ... DAA treatment reduced fibrotic disease burden and lowered the risk of disease progression to cancer or cirrhosis, increasing life expectancy.
SK-Bloom, providing better quality news content.
All News
Others
- Terms of use Terms of use
- Contact Us Contact Us
- Privacy Policy Privacy Policy
2024 Copyright. All Rights Reserved.